Vimarsana
Biggest News Aggregation in the World

Page 9 - Linical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Studies Today - Breaking & Trending Today

Psychotherapy for PTSD Effective Even After Multiple Traumas - Vimarsana News

Psychotherapy for PTSD Effective Even After Multiple Traumas

Psychotherapy works as well for symptoms of posttraumatic stress disorder related to multiple traumatic events as it does for single trauma, a new study showed.

Benefit of Thrombolysis With Thrombectomy Only Given Early? - Vimarsana News

Benefit of Thrombolysis With Thrombectomy Only Given Early?

In patients presenting at thrombectomy-capable stroke centers, the benefit associated with thrombolysis before thrombectomy was time dependent, new data suggested.

Gut Signature for Treatment-Resistant Schizophrenia? - Vimarsana News

Gut Signature for Treatment-Resistant Schizophrenia?

Adults with resistant schizophrenia have significant gut microbiome differences vs their counterparts who respond to treatment, a new finding that may be driven by clozapine treatment.

Total Abstinence Not the Only Treatment Goal in SUD - Vimarsana News

Total Abstinence Not the Only Treatment Goal in SUD

In patients with SUD, even slight reductions in drug use are linked to better outcomes, suggesting abstinence should not be the only goal of treatment, a new analysis showed.

Biogen's Abandonment of AD Drug No Surprise, Experts Say - Vimarsana News

Biogen's Abandonment of AD Drug No Surprise, Experts Say

More than 2 years after its controversial accelerated FDA approval, Biogen says it will halt development and commercialization of aducanumab and focus on lecanemab.